Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production
Vaccines for human use have conventionally been developed by the production of (1) microbial pathogens in eggs or mammalian cells that are then inactivated, or (2) by the production of pathogen proteins in mammalian and insect cells that are purified for vaccine formulation, as well as, more recentl...
Main Authors: | Elizabeth Monreal-Escalante, Abel Ramos-Vega, Carlos Angulo, Bernardo Bañuelos-Hernández |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/1/100 |
Similar Items
-
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
by: Joan Kha-Tu Ho, et al.
Published: (2020-01-01) -
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
by: Brankica Filipić, et al.
Published: (2023-06-01) -
Editorial: The utilization of plants in vaccine research
by: Sezer Okay, et al.
Published: (2023-11-01) -
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
by: Melanie Schwerdtfeger, et al.
Published: (2019-05-01) -
Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens
by: Anna Kirsteina, et al.
Published: (2020-04-01)